Mao Inhibitors + Capmatinib Interaction
Moderateinteraction on record
Description
Coadministration with strong CYP3A inhibitors increased capmatinib exposure, which may increase the incidence and severity of adverse reactions. Closely monitor patients for adverse reactions.
Mechanism
CYP3A inhibition increases capmatinib exposure
Source: NLP:capmatinib